Clinical significance of NOB1 expression in breast infiltrating ductal carcinoma

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 10, 2013, Pages 2137-2144

  Li, Xiao Yu ^a   Luo, Qi Feng ^a   Li, Jia ^a   Wei, Chuan Kui ^a   Kong, Xiang Jie ^a   Zhang, Jun Feng ^a   Fang, Lin ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

Breast cancer; Immunohistochemistry; NOB1 protein; Tissue microarray

Indexed keywords

NOB1 PROTEIN, HUMAN; NUCLEAR PROTEIN; RNA BINDING PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER STAGING; CARCINOGENESIS; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; NOB1 PROTEIN; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; TISSUE MICROARRAY;

BREAST CANCER; IMMUNOHISTOCHEMISTRY; NOB1 PROTEIN; TISSUE MICROARRAY;

ADULT; AGED; BREAST NEOPLASMS; CARCINOGENESIS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; NUCLEAR PROTEINS; PROGNOSIS; RNA-BINDING PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84885342199     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Siegel R, Naishadham D and Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
2. Adriaenssens N, Vinh-Hung V, Miedema G, Versmessen H, Lamote J, Vanhoeij M, Lievens P, van Parijs H, Storme G, Voordeckers M and De Ridder M. Early contralateral shoulder-arm morbidity in breast cancer patients enrolled in a randomized trial of post-surgery radiation therapy. Breast Cancer (Auckl) 2012; 6: 79-93.
3. Zhang BN, Zhang B, Tang ZH, Xie XM, Yang HJ, He JJ, Li H, Li JY, Li J, Fan JH, Huang R, Song QK, Zhang HM and Qiao YL. [10-year changes and development of surgical treatment for breast cancer in China]. Zhonghua Zhong Liu Za Zhi 2012; 34: 582-587.
4. Masinghe SP, Faluyi OO, Kerr GR and Kunkler IH. Breast radiotherapy for occult breast cancer with axillary nodal metastases-does it reduce the local recurrence rate and increase overall survival? Clin Oncol (R Coll Radiol) 2011; 23: 95-100.
5. Zhang Y, Ni J, Zhou G, Yuan J, Ren W, Shan Y, Tang W, Yu L and Zhao S. Cloning, expression and characterization of the human NOB1 gene. Mol Biol Rep 2005; 32: 185-189.
6. Fatica A, Oeffinger M, Dlakic M and Tollervey D. Nob1p is required for cleavage of the 3' end of 18S rRNA. Mol Cell Biol 2003; 23: 1798-1807.
7. Veith T, Wurm JP, Duchardt-Ferner E, Weis B, Martin R, Safferthal C, Bohnsack MT, Schleiff E and Wohnert J. Backbone and side chain NMR resonance assignments for an archaeal homolog of the endonuclease Nob1 involved in ribosome biogenesis. Biomol NMR Assign 2012; 6: 47-50.
8. Tone Y and Toh EA. Nob1p is required for biogenesis of the 26S proteasome and degraded upon its maturation in Saccharomyces cerevisiae. Genes Dev 2002; 16: 3142-3157.
9. Lamanna AC and Karbstein K. Nob1 binds the single-stranded cleavage site D at the 3'-end of 18S rRNA with its PIN domain. Proc Natl Acad Sci U S A 2009; 106: 14259-14264.
10. Hong L, Piao Y, Han Y, Wang J, Zhang X, Du Y, Cao S, Qiao T, Chen Z and Fan D. Zinc ribbon domain-containing 1 (ZNRD1) mediates multidrug resistance of leukemia cells through regulation of P-glycoprotein and Bcl-2. Mol Cancer Ther 2005; 4: 1936-1942.
11. Granneman S, Nandineni MR and Baserga SJ. The putative NTPase Fap7 mediates cytoplasmic 20S pre-rRNA processing through a direct interaction with Rps14. Mol Cell Biol 2005; 25: 10352-10364.
12. Lin Y, Peng S, Yu H, Teng H and Cui M. RNAi-mediated downregulation of NOB1 suppresses the growth and colony-formation ability of human ovarian cancer cells. Med Oncol 2012; 29: 311-317.
13. He XW, Tao F, Luo SS and Yu XK. [Effect of lentivirus-mediated NOB1 gene silencing by RNA interference on proliferation and apoptosis of human colon cancer cells]. Zhonghua Wei Chang Wai Ke Za Zhi 2012; 15: 1182-1186.
14. Wu DP and He XW. [Expression of NOB1 and its significance in colorectal cancer]. Nan Fang Yi Ke Da Xue Xue Bao 2012; 32: 420-422.
15. Lynch HT and Smyrk TC. Identifying hereditary nonpolyposis colorectal cancer. N Engl J Med 1998; 338: 1537-1538.
16. Lecker SH, Goldberg AL and Mitch WE. Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J Am Soc Nephrol 2006; 17: 1807-1819.
17. Baumeister W, Walz J, Zuhl F and Seemuller E. The proteasome: paradigm of a self-compartmentalizing protease. Cell 1998; 92: 367-380.
18. Monticone M, Biollo E, Fabiano A, Fabbi M, Daga A, Romeo F, Maffei M, Melotti A, Giaretti W, Corte G and Castagnola P. z-Leucinyl-leucinyl-norleucinal induces apoptosis of human glioblastoma tumor-initiating cells by proteasome inhibition and mitotic arrest response. Mol Cancer Res 2009; 7: 1822-1834.
19. Glickman MH and Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 2002; 82: 373-428.
20. Voges D, Zwickl P and Baumeister W. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu Rev Biochem 1999; 68: 1015-1068.
21. Hallman J, Persson M and Af Klinteberg B. Female alcoholism: differences between female alcoholics with and without a history of additional substance misuse. Alcohol Alcohol 2001; 36: 564-571.
22. Chen D, Frezza M, Shakya R, Cui QC, Milacic V, Verani CN and Dou QP. Inhibition of the proteasome activity by gallium(III) complexes contributes to their anti prostate tumor effects. Cancer Res 2007; 67: 9258-9265.
23. Hanahan D and Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
24. Johnstone RW, Ruefli AA and Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell 2002; 108: 153-164.
25. Kluge R, Giesen K, Bahrenberg G, Plum L, Ortlepp JR and Joost HG. Quantitative trait loci for obesity and insulin resistance (Nob1, Nob2) and their interaction with the leptin receptor allele (LeprA720T/T1044I) in New Zealand obese mice. Diabetologia 2000; 43: 1565-1572.